GB1141735A - Pharmaceutical anti-tumor composition - Google Patents
Pharmaceutical anti-tumor compositionInfo
- Publication number
- GB1141735A GB1141735A GB1225967A GB1225967A GB1141735A GB 1141735 A GB1141735 A GB 1141735A GB 1225967 A GB1225967 A GB 1225967A GB 1225967 A GB1225967 A GB 1225967A GB 1141735 A GB1141735 A GB 1141735A
- Authority
- GB
- United Kingdom
- Prior art keywords
- benzene
- lapachol
- meoh
- concentrated
- tumor composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000000259 anti-tumor effect Effects 0.000 title 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract 3
- MEPSBMMZQBMKHM-UHFFFAOYSA-N Lomatiol Natural products CC(=C/CC1=C(O)C(=O)c2ccccc2C1=O)CO MEPSBMMZQBMKHM-UHFFFAOYSA-N 0.000 abstract 2
- CIEYTVIYYGTCCI-UHFFFAOYSA-N SJ000286565 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(O)C(=O)C2=C1 CIEYTVIYYGTCCI-UHFFFAOYSA-N 0.000 abstract 2
- 239000000284 extract Substances 0.000 abstract 2
- KNOSIOWNDGUGFJ-UHFFFAOYSA-N hydroxysesamone Natural products C1=CC(O)=C2C(=O)C(CC=C(C)C)=C(O)C(=O)C2=C1O KNOSIOWNDGUGFJ-UHFFFAOYSA-N 0.000 abstract 2
- CWPGNVFCJOPXFB-UHFFFAOYSA-N lapachol Chemical compound C1=CC=C2C(=O)C(=O)C(CC=C(C)C)=C(O)C2=C1 CWPGNVFCJOPXFB-UHFFFAOYSA-N 0.000 abstract 2
- SIUGQQMOYSVTAT-UHFFFAOYSA-N lapachol Natural products CC(=CCC1C(O)C(=O)c2ccccc2C1=O)C SIUGQQMOYSVTAT-UHFFFAOYSA-N 0.000 abstract 2
- -1 CHCl 3 Chemical compound 0.000 abstract 1
- 229930192627 Naphthoquinone Natural products 0.000 abstract 1
- 241000020346 Stereospermum Species 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000391 magnesium silicate Substances 0.000 abstract 1
- 229910052919 magnesium silicate Inorganic materials 0.000 abstract 1
- 235000019792 magnesium silicate Nutrition 0.000 abstract 1
- 150000002791 naphthoquinones Chemical class 0.000 abstract 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
1,141,735. Naphthoquinone derivative. CHAS. PFIZER & CO. Inc. 15 March, 1967 [23 Nov., 1966], No. 12259/67. Heading C2C. [Also in Division A5] The compound lapachol (2-hydroxy-3-(3- methyl-2-butenyl)-1,4-naphthaquinone is obtained by extracting the roots or heartwood of Stereospermum suaveoleus three times with cold ligroin and concentrating the combined extracts. Other solvents, e.g. benzene, CHCl 3 , ethyl acetate, MeOH or aqueous Na 2 C0 3 may be used. If MeOH is employed, the extract is concentrated and shaken with benzene and water. The benzene layer is concentrated and chromatographed on silicic acid/cellulose or magnesium silicate by elution with benzene, the yellow band of lapachol being recovered and recrystallized.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59643766A | 1966-11-23 | 1966-11-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1141735A true GB1141735A (en) | 1969-01-29 |
Family
ID=24387269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1225967A Expired GB1141735A (en) | 1966-11-23 | 1967-03-15 | Pharmaceutical anti-tumor composition |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1141735A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3431236A1 (en) * | 1984-08-24 | 1986-02-27 | Carnivora-Deutschland GmbH, 7109 Jagsthausen | USE OF 1,4-NAPHTHOQUINONE DERIVATIVES IN LOW CONCENTRATIONS FOR IMMUNE STIMULATION |
| WO1994003163A1 (en) * | 1992-08-07 | 1994-02-17 | The Wellcome Foundation Limited | Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer |
| US5998449A (en) * | 1992-11-26 | 1999-12-07 | Glaxo Wellcome Inc. | Combination of atovaquone with proguanil for the treatment of protozoal infections |
| US6018080A (en) * | 1992-12-24 | 2000-01-25 | Glaxo Wellcome Inc. | Atovaquone pharmaceutical compositions |
-
1967
- 1967-03-15 GB GB1225967A patent/GB1141735A/en not_active Expired
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3431236A1 (en) * | 1984-08-24 | 1986-02-27 | Carnivora-Deutschland GmbH, 7109 Jagsthausen | USE OF 1,4-NAPHTHOQUINONE DERIVATIVES IN LOW CONCENTRATIONS FOR IMMUNE STIMULATION |
| WO1994003163A1 (en) * | 1992-08-07 | 1994-02-17 | The Wellcome Foundation Limited | Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer |
| US5567738A (en) * | 1992-08-07 | 1996-10-22 | Glaxo Wellcome Inc. | Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-Naphthoquinone for the treatment of cancer |
| AU676687B2 (en) * | 1992-08-07 | 1997-03-20 | Wellcome Foundation Limited, The | Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1, 4-naphthoquinone for the treatment of cancer |
| US5998449A (en) * | 1992-11-26 | 1999-12-07 | Glaxo Wellcome Inc. | Combination of atovaquone with proguanil for the treatment of protozoal infections |
| US6166046A (en) * | 1992-11-26 | 2000-12-26 | Glaxo Wellcome Inc. | Combination of atovaquone with proguanil for the treatment of protozoal infections |
| US6291488B1 (en) | 1992-11-26 | 2001-09-18 | Glaxo Wellcome Inc. | Preventing protozoal infections |
| US6018080A (en) * | 1992-12-24 | 2000-01-25 | Glaxo Wellcome Inc. | Atovaquone pharmaceutical compositions |
| US6649659B1 (en) | 1992-12-24 | 2003-11-18 | Smithkline Beecham Corporation | Atovaquone pharmaceutical compositions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1376096A (en) | 1-3,4-methylenedioxy-phenyl-4,4-dimethyl-1-pentene derivatives | |
| GB1263000A (en) | 4,4',4''-trihydroxytriphenylmethylmethane and process for preparing it | |
| GB1141735A (en) | Pharmaceutical anti-tumor composition | |
| BE603824A (en) | New derivatives of indan-dione-1,3 and methods of preparation thereof | |
| GB1282764A (en) | Imidazoline-2-thiones | |
| GB1141392A (en) | A 4-aminoquinaldine derivative, its preparation and pharmaceutical compositions containing it | |
| FR1610M (en) | New drugs consisting of (p-acyloxy-phenoxy) -benzoic acid derivatives. | |
| CA604830A (en) | Locking means for axial flow turbo-machine blading | |
| AU254698B2 (en) | New derivatives of indane-1, 3-dione and processes forthe preparation of such derivatives | |
| AU493861A (en) | New derivatives of indane-1, 3-dione and processes forthe preparation of such derivatives | |
| TAKEMURA | On the “gold-lipped” and “silver-lipped” shells of the pearl oyster (Pinctada maxima) | |
| GB1276097A (en) | Improvements in or relating to phloroglucinol derivatives | |
| Akuta et al. | Effect of Condiments which Influence the Vitamin B1 and B2 Contests of Fortified Miso-soup | |
| JPS535128A (en) | Preparation of isoprenoid derivatives | |
| YAMADA | Effects of free chlorine on the respiration of seaweeds | |
| AU1073561A (en) | Improvements in or relating to 2, 8-diazaspiro 4, 5] decane-1, 3-dione derivatives | |
| CA604100A (en) | Oxygenated solid bromine derivatives and method of producing them | |
| ES368038A1 (en) | Procedure for the obtaining of a peroxide of metiletil-cetona-cycle-hexanone (or its derivatives). (Machine-translation by Google Translate, not legally binding) | |
| CA617233A (en) | Derivatives of cinnamaldehyde and 2-thienyl-acrolein and method of preparation thereof | |
| GB1159483A (en) | Process for the Preparation of Benzyl Alcohol | |
| KAWASE | On the Extract Powder of Keishito and Kakkonto | |
| AU282117B2 (en) | 20-nitrogen derivatives of 19-nor-pregna-1,3,5(10)-trienes and their preparation | |
| CA605986A (en) | Method of preparing diamino-n,n-n',n'-tetrakisphosphoric acid derivatives | |
| GB1217209A (en) | A novel isopropanol derivative, the preparation thereof and compositions containing the same | |
| AU248068B2 (en) | 4-hydroxycoumarin derivatives and processes for the preparation thereof |